(Centro Nacional de Investigaciones Oncológicas (CNIO)) A study published in Nature Medicine by researchers from the Spanish National Cancer Research Centre (CNIO) suggests that prolonged use of Plk1 inhibitors, which are currently in clinical trials with patients, can not only lead to hypertension issues but also to the rupturing of blood vessels and severe cardiovascular problems.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2u5DHzL
No comments:
Post a Comment